David Evans

Chief Scientific Officer
Dr. Evans obtained his BSc and PhD from Imperial College, London. Over the last 3 decades he has built and lead scientific research teams focused on target validation, high throughput screening and preclinical testing of small molecules and siRNAs in Oncology and other indications. David has more than 15 years’ experience in the RNAi field – as Head of Drug Discovery for the Cancer Drug Development Lab for TGEN and as Sr. Director, RNAi Discovery and Therapeutic Services for Dharmacon (Thermo Fisher Scientific) - prior to cofounding Sirnaomics to focus on developing siRNA/miRNAs as therapeutics. David previously worked in the Boston area with Millennium and Serono Pharmaceuticals and at Frederick National Lab for Cancer Research. 


No data was found

Download Brochure

Full details regarding the R&D Series are available for download in the Conference Brochure